Clinical Trial Update: Neoadjuvant Combined Endocrine and HER2 Target Therapy in Postmenopausal Women With ER and Her2 Positive Breast Cancer [Phase 2]

View source ↗

Summary

The Phase 2 neoadjuvant trial NCT01275859 evaluating combined endocrine and HER2-targeted therapy in postmenopausal women with ER-positive and HER2-positive bre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Asan Medical Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED